Skip to main content
HERCESSI 150 mg/7.4mL injection, powder, lyophilized, for solution by Accord BioPharma Inc.
HERCESSI, 150 mg/7.4mL, injection, powder, lyophilized, for solution Drug class: HER2/neu Receptor Antagonist. Available on prescription only. Listed by Accord BioPharma Inc..
Prescription only

HERCESSI

Trastuzumab-strf

Listed by Accord BioPharma Inc.

Strength
150 mg/7.4mL
Form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Class
HER2/neu Receptor Antagonist

What it contains

  • Trastuzumab-strf 150 mg/7.4mL

FDA record

Dosage form Injection, Powder, Lyophilized, For Solution
Route Intravenous
Drug class HER2/neu Receptor Antagonist
Approval route BLA — biologic licence
NDC code 69448-015
FDA application BLA761346
Package sizes listed 1
Marketed since January 2025

Other products containing Trastuzumab Strf

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

HERCESSI

Trastuzumab-strf

Strength
420 mg/20mL
Form
Injection, Powder, Lyophilized, For Solution
Class
HER2/neu Receptor Antagonist
Rx only

Accord BioPharma Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.